文献速递肝胆胰外科胃肠外科

胰十二指肠切除术后R0与R1切除对胰腺癌预后影响:系统评价与队列研究

R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer.
PubMed 文献 · Ann Surg · 2018-01-01

该研究通过Meta分析和单中心回顾性队列(254例)探讨R0与R1切除对胰腺导管腺癌(PDAC)生存的影响。结果显示R1与总生存(HR 1.45,95%CI 1.37-1.52)和无病生存(HR 1.44,95%CI 1.30-1.59)下降相关,但该效应仅见于胰头切除术。2010年前因病理评估异质性,切除边缘的预后价值有限。

要点

  • 在标准化病理方案下,R1切除与PDAC患者总生存和无病生存显著下降相关。
  • R1的预后不良效应主要局限于胰头癌,胰体尾或全胰切除中证据不足。
  • R1切除常与更大肿瘤、淋巴结转移和联合切除等进展期特征相关。

核心结论

  • 在标准化病理评估下,R0与R1切除对胰腺癌生存的影响在胰头切除术中显著,但在胰体尾或全胰切除术中不明显。

研究设计与样本

  • 系统检索Pubmed、Embase和Cochrane数据库,对预后研究进行Meta分析,并回顾性分析单中心前瞻数据库2007年7月至2014年10月间254例根治性PDAC切除患者。

主要发现

  • Meta分析中,R1相比R0与总生存下降相关(HR 1.45,95%CI 1.37-1.52),无病生存下降相关(HR 1.44,95%CI 1.30-1.59)。
  • 该效应仅在胰头切除术中显著:Meta分析中R0≥0 mm的HR为1.21(95%CI 1.05-1.39),R0≥1 mm的HR为1.66(95%CI 1.46-1.89)。
  • 本队列中胰头切除术R0≥0 mm时R0与R1的中位生存分别为31.8个月和14.5个月(P<0.001),R0≥1 mm时分别为41.2个月和16.8个月(P<0.001)。
  • R1切除与更大肿瘤、淋巴结转移和联合切除等进展期特征相关。
  • 多变量Cox模型提示G3、pN1、肿瘤大小和R1(0 mm/1 mm)是总生存的独立预测因素。

临床怎么用

  • 在胰头癌胰十二指肠切除术后,应追求R0切除并标准化病理评估以准确判断R状态。
  • 对于胰体尾或全胰切除术,R1的预后意义可能有限,需结合其他因素综合评估。
  • R1切除提示进展期疾病特征,术后应考虑更密切的随访或辅助治疗。

局限性

  • 2010年前的文献因队列异质性和缺乏标准化病理检查,切除边缘的预后价值有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to decipher the true importance of R0 versus R1 resection for survival in pancreatic ductal adenocarcinoma (PDAC). SUMMARY OF BACKGROUND DATA: PDAC is characterized by poor survival, even after curative resection. In many studies, R0 versus R1 does not result in different prognosis and does not affect the postoperative management. METHODS: Pubmed, Embase, and Cochrane databases were screened for prognostic studies on the association between resection status and survival. Hazard ratios (HRs) were pooled in a meta-analysis. Furthermore, our prospective database was retrospectively screened for curative PDAC resections according to inclusion criteria (n = 254 patients) between July 2007 and October 2014. RESULTS: In the meta-analysis, R1 was associated with a decreased overall survival [HR 1.45 (95% confidence interval, 95% CI 1.37-1.52)] and disease-free survival [HR 1.44 (1.30-1.59)] in PDAC when compared with R0. Importantly, this effect held true only for pancreatic head resection both in the meta-analysis [R0 ≥0 mm: HR 1.21 (1.05-1.39) vs R0 ≥1 mm: HR 1.66 (1.46-1.89)] and in our cohort (R0 ≥0 mm: 31.8 vs 14.5 months, P < 0.001; R0 ≥1 mm, 41.2 vs 16.8 months; P < 0.001). Moreover, R1 resections were associated with advanced tumor disease, that is, larger tumor size, lymph node metastases, and extended resections. Multivariable Cox proportional hazard model suggested G3, pN1, tumor size, and R1 (0 mm/1 mm) as independent predictors of overall survival. CONCLUSION: Resection margin is not a valid prognostic marker in publications before 2010 due to heterogeneity of cohorts and lack of standardized histopathological examination. Within standardized pathology protocols, R-status' prognostic validity may be primarily confined to pancreatic head cancers.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Demir IE, Jäger C, Schlitter AM, et al. R0 Versus R1 Resection Matters after Pancreaticoduodenectomy, and Less after Distal or Total Pancreatectomy for Pancreatic Cancer. Ann Surg. 2018. PMID: 28692477. doi:10.1097/SLA.0000000000002345

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。